India regulator approves AstraZeneca COVID vaccine, country’s first: Sources
India’s drug regulator on Friday approved a coronavirus vaccine developed by AstraZeneca and Oxford University for emergency use, two sources
with knowledge of the matter told Reuters.
For more coronavirus news, visit our dedicated page.
The approval paves the way for its rollout in the world’s second worst affected country.
For all the latest headlines follow our Google News channel online or via the app
A representative of India’s Central Drugs Standard Control Organization (CDSCO), whose experts are meeting for the second time this week and also considering two other vaccines, declined to comment.
Read more: AstraZeneca vaccine should combat COVID-19 variant
Britain and Argentina have already authorized the vaccine for urgent public use.
India wants to start administering the shots soon.
It is also considering emergency-use authorization applications for vaccines made by Pfizer Inc with Germany’s BioNTech, and by India’s Bharat Biotech.
At more than 10 million, India has reported the second highest number of coronavirus cases after the United States, though its rate of infection has come down significantly from a mid-September peak.
Also Read
-
BioNTech to boost vaccine production, say can’t fully cover lack of other vaccines
BioNTech is working flat out with partner Pfizer to boost production of their COVID-19 vaccine, its founders said, warning there would be gaps in ... Coronavirus -
Coronavirus: Pfizer/BioNTech first vaccine to get WHO validation for emergency use
The World Health Organization (WHO) granted emergency validation to the Pfizer-BioNTech coronavirus vaccine on Thursday, making it the first vaccine ... Coronavirus -
Coronavirus: What we know about China's vaccine development, efficacy data, timelines
China was ahead in the global race to develop coronavirus vaccines with the most candidates in late stage of trials earlier in the year and its first ... Coronavirus -
Coronavirus: Local funding crisis threatens US COVID-19 vaccine rollout
Seattle public health officials have so little COVID-19 funding on hand they worry they will have to shut down some virus testing sites as they mount ... Coronavirus -
AstraZeneca vaccine should combat COVID-19 variant
The head of drug maker AstraZeneca, which is developing a coronavirus vaccine widely expected to be approved by UK authorities this week, said Sunday ... World News
